| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 2429 |
| 1 | TOCILIZUMAB | 2334 |
| 2 | ADALIMUMAB | 2332 |
| 3 | METHOTREXATE | 2329 |
| 4 | DICLOFENAC SODIUM | 2322 |
| 5 | DICLOFENAC | 2302 |
| 6 | PREDNISONE | 2274 |
| 7 | RITUXIMAB | 2264 |
| 8 | LEFLUNOMIDE | 2256 |
| 9 | SULFASALAZINE | 2231 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAFFEINE CITRATE | 533 | 0.2444 |
| 1 | TRIPROLIDINE HYDROCHLORIDE | 41 | 0.2330 |
| 2 | TRICLOSAN | 114 | 0.2271 |
| 3 | NEOMYCIN OINTMENT | 445 | 0.1935 |
| 4 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 111 | 0.1829 |
| 5 | DICLOFENAC POTASSIUM TABLETS | 1278 | 0.1598 |
| 6 | PSEUDOEPHEDRINE HCL | 1666 | 0.1566 |
| 7 | HYDROCORTISONE BUTYRATE | 287 | 0.1561 |
| 8 | CORTISONE ACETATE | 1722 | 0.1432 |
| 9 | DICLOFENAC POTASSIUM | 1278 | 0.1235 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 2484 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 2470 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 2442 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 2327 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2325 |
| 5 | Vitamin C [EPC] | 2324 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 2277 |
| 7 | Aminosalicylate [EPC] | 2268 |
| 8 | Antirheumatic Agent [EPC] | 2256 |
| 9 | Vitamin B12 [EPC] | 2242 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antirheumatic Agent [EPC] | 2256 | 0.0218 |
| 1 | Endoglycosidase [EPC] | 199 | 0.0208 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 2470 | 0.0187 |
| 3 | Interleukin-12 Antagonist [EPC] | 1843 | 0.0183 |
| 4 | Aminosalicylate [EPC] | 2268 | 0.0174 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 331 | 0.0173 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 2163 | 0.0160 |
| 7 | Tetracycline-class Drug [EPC] | 966 | 0.0143 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 1139 | 0.0141 |
| 9 | Phosphodiesterase 4 Inhibitor [EPC] | 1475 | 0.0092 |